Johnson & Johnson Innovation News and Activities
Presence
Johnson & Johnson is one of the...
- Forbes Global 2000 (#42);
- Fortune 500 (#42);
- Global Fortune 500 (#48);
- Russell 3000;
- S&P 500;
- TOB Iconic 10,000.
Johnson & Johnson is a company listed under the stock ticker JNJ (US).
Johnson & Johnson has a direct presence in 23 countries.Johnson & Johnson has 62 subsidiaries including Abiomed, Ambrx and DePuy Synthes.
They are in:
- Pharmaceuticals63%
- Medical Equipment19%
- Other17%
Acquisition, funding and merger involving Johnson & Johnson.
- Johnson & Johnson has announced the acquisition of Intra-Cellular Therapies (posted on January 13 2025).
- Johnson & Johnson has acquired V-Wave (posted on October 9 2024).
- Johnson & Johnson has announced the acquisition of Proteologix (posted on June 21 2024).
- Johnson & Johnson has announced the acquisition of Proteologix (posted on May 20 2024).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (posted on April 6 2024).
- Johnson & Johnson has acquired Ambrx (posted on January 11 2024).
- See more news about Johnson & Johnson Hide news involving Johnson & Johnson
Executives
View the org chart displaying its 26 main executives
Most searched biographies at Johnson & Johnson Innovation
- Chris Picariello, President
- Melinda Richter, Global Head of JLabs
- Stacy Feld, Regional Head, West North America
Popular executive movements at Johnson & Johnson
- Daniel Pinto has joined the company as Director (posted on June 16 2025).
- Michele LeSueur has joined the company as Vice President, Sales and Marketing (posted on June 16 2025).
- Daniel Pinto has joined the company as Director (posted on June 11 2025).
Click here to view some more movements at Johnson & Johnson
Create your alert
to follow the executive moves at Johnson & Johnson Innovation.
Biotechnology
Johnson & Johnson has 2,347 competitors including Incyte (United States (USA)), Anthos Therapeutics (United States (USA)) and Valneva (France).
Popular M&A news in Biotechnology
- The new name of Synaptogenix is TAO Synergies. (posted on July 3 2025).
- AbbVie has announced the acquisition of Capstan Therapeutics (posted on July 1 2025).
- Neuron23 has just announced a $97 Million fundraising (posted on June 30 2025).
Popular contacts in Biotechnology
News
Press releases by Johnson & Johnson Innovation
- Paige Announces Collaboration to Deploy a Novel AI-Based Biomarker Test for Advanced Bladder Cancer in Clinical Settings
- Serotiny Announces a Research Collaboration With Janssen to Optimize Designs for Chimeric Antigen Receptors Signaling Domains
- Locus Biosciences Announces $35 Million Financing
- Bioasis Enters Into Research Collaboration With Janssen
- Bioasis Enters Into Research Collaboration With Janssen
- ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
- Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies | Fate Therapeutics, Inc.
- OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing
- Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen
- Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
- View more press releases Close
Social media about Johnson & Johnson Innovation
- Johnson & Johnson Innovation on Wikipedia, Google News & Yahoo Finance
- Johnson & Johnson Innovation on LinkedIn, Twitter & YouTube
